Common Contracts

EXECUTION VERSION March 11, 2019 SECURITIES PURCHASE AGREEMENT AMONG BIOBLAST pharma ltd. and THE INVESTORS PARTY HERETO

Securities Purchase Agreement • May 5th, 2020

• Contract Type
  Securities Purchase Agreement
• Filed
  May 5th, 2020

SECURITIES PURCHASE AGREEMENT AMONG BIOBLAST pharma ltd. and THE INVESTORS PARTY HERETO

Securities Purchase Agreement • March 27th, 2019 • Enlivex Therapeutics Ltd. • Pharmaceutical preparations

• Contract Type
  Securities Purchase Agreement
• Filed
  March 27th, 2019
• Company
  Enlivex Therapeutics Ltd.
• Industry
  Pharmaceutical preparations

THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of March 11, 2019, is by and among BioBlast Pharma Ltd., a company formed under the laws of the State of Israel (the “Company”), and each investor identified on the signature pages hereto (each, an “Investor” and collectively, the “Investors”).